about
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is current...
Read More
2.50
-0.04
(-1.57%)
3.8M
XNAS Volume
XNAS 02 Apr, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Mannkind Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..